A 5 year extension to the Emory Angioplasty Surgery Trial (EAST) is proposed. EAST is a prospective trial of 392 patients with multivessel coronary artery disease randomized to percutaneous transluminal coronary angioplasty or coronary artery bypass surgery to study the relative long- term efficacy of these procedures. From 842 eligible patients, 392 were randomized between 7/15/87 and 4/15/90. The patients were randomized within the four strata of 1) two vessel disease with one lesion per vessel, 2) two vessel disease with multiple lesions per vessel, 3) three disease vessel with one lesion per vessel and 4) three vessel disease with multiple lesions per vessel. The primary end point of the original EAST grant is the composite of death, new Q wave myocardial infarction, or large reversible thallium defect. Secondary end points are coronary arteriographic status, additional revascularization, symptoms, ability to exercise, quality of life, and cost. Coronary artery disease is a chronic disease. While a lot will be learned from the first three years of EAST, more will be learned by following these patients out to 8 years. Follow-up events including death, myocardial infarction and additional revascularization procedures will be followed. The cause of death, whether cardiac or not, will be determined by the investigators. Myocardial infarctions will be characterized as non-Q or Q-wave. Additional revascularization procedures will be characterized as either coronary angioplasty or coronary surgery and will be analyzed as to whether the additional procedure is performed for an initially unsuccessful procedure, graft failure or restenosis, incomplete original revascularization or progression of disease. The presence of angina will be assessed yearly, as will use of antianginal medications. Similar data will be gathered on the randomized and eligible but not randomized patients. The data will be stored in the EAST database maintained at Emory University in the biostatistical coordinating center for EAST. The long-term outcome will be compared in the two treatment arms for each of the noted end points, as well as combined end points, using standard statistical methods. These data will be analyzed for the randomized patients and separately for the eligible patients. These detailed analyses will also be performed for each strata. For time dependent end points, Cox model analysis and for nontime dependent analyses stepwise logistic regression will be used to determine correlates of outcome. Thus, the EAST extension will offer the opportunity to provide an in- depth and long-term comparison of the two methods of revascularization for coronary artery disease in an extremely well characterized group of patients randomly assigned to coronary angioplasty or coronary surgery.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033965-08
Application #
2217425
Study Section
Clinical Trials Review Committee (CLTR)
Project Start
1987-06-01
Project End
1997-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Houser, Steven R (2005) Can novel therapies for arrhythmias caused by spontaneous sarcoplasmic reticulum Ca2+ release be developed using mouse models? Circ Res 96:1031-2
Zhao, Xue-Qiao; Kosinski, Andrzej S; Barnhart, Huiman X et al. (2003) Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial. Med Sci Monit 9:CR48-54
Becker, E R; Mauldin, P D; Culler, S D et al. (2000) Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial. Am J Cardiol 85:685-91
King 3rd, S B; Kosinski, A S; Guyton, R A et al. (2000) Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol 35:1116-21
Alazraki, N P; Krawczynska, E G; Kosinski, A S et al. (1999) Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). Am J Cardiol 84:1369-74
King 3rd, S B (1999) The Emory Angioplasty vs Surgery Trial (EAST). Semin Interv Cardiol 4:185-90
King 3rd, S B; Barnhart, H X; Kosinski, A S et al. (1997) Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 79:1453-9
Lee, J S; Bailey, M J; Jeong, J et al. (1997) A study on the cost-effectiveness of coronary revascularization: introducing the simultaneous mimic health status model. Health Econ 6:613-23
Zhao, X Q; Brown, B G; Stewart, D K et al. (1996) Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. Circulation 93:1954-62
Weintraub, W S; Mauldin, P D; Becker, E et al. (1995) A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation 92:2831-40

Showing the most recent 10 out of 12 publications